Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending September 2, 2003. The report primarily discloses a share repurchase transaction and updates regarding director interests in the company's US Retirement Savings Plan.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only specific financial data disclosed relates to a share buyback:
- Shares Repurchased: 800,000 ordinary shares.
- Repurchase Date: September 1, 2003.
- Price per Share: 1,232.24p.
- US Retirement Savings Plan ADRs: Increased from 18,974,180 to 19,099,918 at an average price of $38.83.
Material Changes
The filing details a reduction in the company's share count due to the cancellation of 800,000 ordinary shares. Additionally, the number of American Depositary Receipts (ADRs) held by the company's US Retirement Savings Plan increased by 125,738 shares due to fund movements on August 29, 2003.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, future guidance, outlook, risk factors, contingencies, or unusual items beyond the routine disclosure of the share repurchase and director interest updates.
Investor Verification Checklist
- Verify the total number of shares outstanding following the cancellation of 800,000 shares.
- Confirm the total capital expenditure allocated to the share buyback program authorized at the May 19, 2003 Annual General Meeting.
- Review the full details of the US Retirement Savings Plan to understand the extent of director Dr. J.P. Garnier's potential interest.